Amitis Ramezani

2.2k total citations
139 papers, 1.7k citations indexed

About

Amitis Ramezani is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Amitis Ramezani has authored 139 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Epidemiology, 53 papers in Infectious Diseases and 52 papers in Hepatology. Recurrent topics in Amitis Ramezani's work include Hepatitis B Virus Studies (59 papers), Hepatitis C virus research (47 papers) and Hepatitis Viruses Studies and Epidemiology (22 papers). Amitis Ramezani is often cited by papers focused on Hepatitis B Virus Studies (59 papers), Hepatitis C virus research (47 papers) and Hepatitis Viruses Studies and Epidemiology (22 papers). Amitis Ramezani collaborates with scholars based in Iran, United States and Cuba. Amitis Ramezani's co-authors include Mohammad Banifazl, Arezoo Aghakhani, Ali Eslamifar, Ali Akbar Velayati, Masoomeh Sofian, Mona Sadat Larijani, Minoo Mohraz, Latif Gachkar, Fakher Rahim and R Hamkar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and PLoS Pathogens.

In The Last Decade

Amitis Ramezani

129 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amitis Ramezani Iran 22 1.1k 734 530 203 146 139 1.7k
Arezoo Aghakhani Iran 20 960 0.9× 706 1.0× 269 0.5× 202 1.0× 103 0.7× 94 1.4k
Mohammad Banifazl Iran 20 914 0.9× 682 0.9× 363 0.7× 189 0.9× 66 0.5× 97 1.3k
Valeria Ghisetti Italy 29 1.3k 1.2× 751 1.0× 868 1.6× 34 0.2× 238 1.6× 140 2.8k
Antonio Rivero‐Juárez Spain 23 754 0.7× 1.5k 2.0× 919 1.7× 151 0.7× 95 0.7× 172 1.9k
Larry I. Lutwick United States 21 787 0.7× 269 0.4× 527 1.0× 76 0.4× 50 0.3× 85 1.6k
Matthew J. Hepburn United States 22 404 0.4× 161 0.2× 552 1.0× 130 0.6× 94 0.6× 49 1.4k
Luisa Romanò Italy 34 2.3k 2.1× 2.2k 3.0× 882 1.7× 63 0.3× 78 0.5× 114 3.2k
Howard A. Fields United States 34 1.9k 1.8× 2.9k 3.9× 1.6k 2.9× 220 1.1× 68 0.5× 115 3.7k
Francisco José Dutra Souto Brazil 25 979 0.9× 1.1k 1.5× 487 0.9× 51 0.3× 34 0.2× 87 1.6k
Richard Goodgame United States 26 864 0.8× 144 0.2× 809 1.5× 143 0.7× 64 0.4× 61 2.1k

Countries citing papers authored by Amitis Ramezani

Since Specialization
Citations

This map shows the geographic impact of Amitis Ramezani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amitis Ramezani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amitis Ramezani more than expected).

Fields of papers citing papers by Amitis Ramezani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amitis Ramezani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amitis Ramezani. The network helps show where Amitis Ramezani may publish in the future.

Co-authorship network of co-authors of Amitis Ramezani

This figure shows the co-authorship network connecting the top 25 collaborators of Amitis Ramezani. A scholar is included among the top collaborators of Amitis Ramezani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amitis Ramezani. Amitis Ramezani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karizi, Shohreh Zare, Vahid Ezzatizadeh, Fatemeh Karimi, et al.. (2025). Determination of Prevalence and Genotype Distribution of High‐Risk Human Papillomavirus in Varamin (Iran). Diagnostic Cytopathology. 53(7). 325–332. 2 indexed citations
2.
Larijani, Mona Sadat, et al.. (2024). Assessment of COVID‐19 Vaccine Impact on Women’s Menstrual Health within an 18‐Month Follow‐Up. Obstetrics and Gynecology International. 2024(1). 7344506–7344506.
3.
Larijani, Mona Sadat, Alireza Biglari, Mostafa Salehi‐Vaziri, et al.. (2024). Lessons from COVID-19 Pandemic: A Successful Policy and Practice by Pasteur Institute of Iran. PubMed. 28(1). 1–7.
4.
Eybpoosh, Sana, et al.. (2023). Assessment of long-term adverse events regarding different COVID-19 vaccine regimens within an 18-month follow-up study. Pathogens and Disease. 81. 15 indexed citations
5.
Larijani, Mona Sadat, et al.. (2023). A Landscape on Disorders Following Different COVID-19 Vaccination: A Systematic Review of Iranian Case Reports. Preprints.org. 6 indexed citations
6.
7.
Larijani, Mona Sadat, et al.. (2023). A landscape on disorders following different COVID-19 vaccination: a systematic review of Iranian case reports. European journal of medical research. 28(1). 542–542. 7 indexed citations
8.
Larijani, Mona Sadat, et al.. (2022). Determination of Human Papillomavirus Type 18 Lineage of E6: A Population Study from Iran. BioMed Research International. 2022(1). 2839708–2839708. 6 indexed citations
9.
Ramezani, Amitis, et al.. (2022). Evaluating the Factors Affecting COVID-19 Patients’ Mortality in Arak in 2020. Canadian Respiratory Journal. 2022. 1–8. 2 indexed citations
10.
Khansarinejad, Behzad, et al.. (2022). SARS-CoV-2 Viral Shedding and Associated Factors among COVID-19 Inpatients and Outpatients. Interdisciplinary Perspectives on Infectious Diseases. 2022. 1–6. 2 indexed citations
11.
Larijani, Mona Sadat, et al.. (2021). HIV-1 p24-nef DNA Vaccine Plus Protein Boost Expands T-Cell Responses in BALB/c. Current Drug Delivery. 18(7). 1014–1021. 7 indexed citations
12.
Larijani, Mona Sadat, Mohammad Hassan Pouriayevali, Seyed Mehdi Sadat, & Amitis Ramezani. (2020). Production of Recombinant HIV-1 p24-Nef Protein in Two Forms as Potential Candidate Vaccines in Three Vehicles. Current Drug Delivery. 17(5). 387–395. 10 indexed citations
13.
Larijani, Mona Sadat, Amitis Ramezani, & Seyed Mehdi Sadat. (2019). Updated Studies on the Development of HIV Therapeutic Vaccine. Current HIV Research. 17(2). 75–84. 18 indexed citations
14.
Mahmoudi, Shima, et al.. (2015). Adverse reactions toMycobacterium bovisbacille Calmette-Guérin vaccination against tuberculosis in Iranian children. Clinical and Experimental Vaccine Research. 4(2). 195–195. 11 indexed citations
15.
Ramezani, Amitis, Mohammad Banifazl, & Arezoo Aghakhani. (2013). GB Virus C Overview: Insights into Clinical Implication. Journal of Gastroenterology and Hepatology Research. 2(1). 343–349. 1 indexed citations
16.
Ramezani, Amitis, Mohammad Banifazl, & Arezoo Aghakhani. (2011). Occult hepatitis B infection in chronic hemodialysis patients: Comparison of results and concepts. Hepatitis Monthly. 11(231). 128–129. 4 indexed citations
17.
Ramezani, Amitis, Mohammad Banifazl, Minoo Mohraz, Mehrnaz Rasoolinejad, & Arezoo Aghakhani. (2011). Occult hepatitis B virus infection: A major concern in HIV-infected patients. Hepatitis Monthly. 11(130). 7–10. 36 indexed citations
18.
Ramezani, Amitis, Minoo Mohraz, Mohammad Banifazl, et al.. (2009). Prevalence of Dyslipidemia and Metabolic Abnormalities in HIV-Infected Patients. SHILAP Revista de lepidopterología. 47(2). 83–88. 6 indexed citations
19.
Ramezani, Amitis, Arezoo Aghakhani, Fakher Rahim, et al.. (2009). ASSOCIATION BETWEEN HEPATITIS B VIRUS INFECTION OUTCOME AND HLA-A AND DRB1 GENOTYPING IN NORTH PART OF IRAN. Iranian journal of pathology. 4(2). 71–74. 2 indexed citations
20.
Eslamifar, Ali, et al.. (2008). FREQUENCY AND IDENTIFICATION OF FUNGAL STRAINS IN PATIENTS WITH CHRONIC RHINOSINUSITIS. Iranian journal of pathology. 3(3). 135–139. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arezoo Aghakhani Breakdown of academic impact, for papers by Mohammad Banifazl Breakdown of academic impact, for papers by Valeria Ghisetti Breakdown of academic impact, for papers by Antonio Rivero‐Juárez Breakdown of academic impact, for papers by Larry I. Lutwick Breakdown of academic impact, for papers by Matthew J. Hepburn Breakdown of academic impact, for papers by Luisa Romanò Breakdown of academic impact, for papers by Howard A. Fields Breakdown of academic impact, for papers by Francisco José Dutra Souto Breakdown of academic impact, for papers by Richard Goodgame
Rankless by CCL
2026